Invention Grant
- Patent Title: GLP-1R receptor agonist compound and use thereof
-
Application No.: US18192735Application Date: 2023-03-30
-
Publication No.: US11773087B2Publication Date: 2023-10-03
- Inventor: Ben Li , Shanghai Yu
- Applicant: SUZHOU VINCENTAGE PHARMA CO., LTD
- Applicant Address: CN Jiangsu
- Assignee: SUZHOU VINCENTAGE PHARMA CO., LTD
- Current Assignee: SUZHOU VINCENTAGE PHARMA CO., LTD
- Current Assignee Address: CN Jiangsu
- Agency: Houston Beshining Law Office PLLC
- Agent Liangang Ye
- Priority: CN 2011406013.0 2020.12.03 CN 2110334388.9 2021.03.29
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D405/06 ; C07D401/06 ; C07D401/14 ; C07D471/04 ; A61P3/10

Abstract:
The present invention relates to a GLP-1R receptor agonist compound and a use thereof. Specifically, the present invention discloses a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound can be used for treating a metabolism-related disease, such as diabetes or nonalcoholic fatty liver disease, by means of activating GLP-1R receptors.
Public/Granted literature
- US20230257369A1 GLP-1R RECEPTOR AGONIST COMPOUND AND USE THEREOF Public/Granted day:2023-08-17
Information query